|
|
|
|
Andrew D. Dickinson is President, Treasurer & Director at Immunomedics, Inc.
He is also on the board of Fosun Kite Biotechnology Co., Ltd. and Gilead Sciences Ltd. and Chief Financial Officer for Gilead Sciences, Inc.
In his past career Mr. Dickinson was Founding Partner of Kendall Dickinson & Koenig LLC, Co-Head-Healthcare Investment Banking at Lazard Ltd. and Secretary, Vice President & General Counsel at Myogen, Inc.
He received a graduate degree from Loyola University of Chicago and an undergraduate degree from The University of Colorado.
|
| Aktuelle Stellungen und Verantwortungsbereiche Andrew Dickinson | |
|
| Name | Titel |
Seit |
 Gilead Sciences, Inc.
(Biotechnologie) |
Chief Financial Officer |
2019 | Immunomedics, Inc.
(Biotechnologie) |
President, Treasurer & Director |
2020 | Forty Seven, Inc.
(Biotechnologie) |
President, Treasurer & Director |
2020 | | Fosun Kite Biotechnology Co., Ltd. |
Director |
- | | Gilead Sciences Ltd. |
Director |
2019 |
|
| Anteile an Andrew Dickinson | |
|
|
| Andrew Dickinson : Persönliches Netzwerk | |
|
| Name | Verbundene Unternehmen |
| Brett A. Pletcher | Gilead Sciences, Inc.
Immunomedics, Inc.
Forty Seven, Inc.
Gilead Sciences Ltd. |
| Loretta M. Itri | Immunomedics, Inc. |
| Chau Cheng | Immunomedics, Inc. |
| Kyle C. Elrod | Forty Seven, Inc. |
| Kurt J. W. Andrews | Immunomedics, Inc. |
| Usama Malik | Immunomedics, Inc. |
| Craig S. Gibbs | Forty Seven, Inc. |
| Xia Zhao | Forty Seven, Inc. |
| Jens-Peter Volkmer | Forty Seven, Inc. |
| Mark Chao | Forty Seven, Inc. |
|
© 2021 People and Ownership : 
|
|
|
| Andrew Dickinson : Verbindungen | |
|
|
| Aktuelle Nachrichten zu Andrew Dickinson | |
|
|
|
|
Canada
España
France
Italia
Schweiz (DE)
United Kingdom
United States
